> With a little ___domain knowledge and research you find out pretty quickly
That's cool. Where do you think that ___domain knowledge comes from? Did we just found it in a fortune cookie? Or does the cancer research conducted has something to do with that we have this knowledge?
> BCL6 is lymphoma.
That's not correct. BCL6 is a protein, or a gene which codes that protein. Mutations in BCL6 can lead to B cell lymphomas. BCL6 is not lymphoma.
> I am saying that it seems very straightforward as an approach to attempt to trigger a CDK cell death when BCL6 is present.
Excellent. Sounds like you are an oracle of oncological research roadmap. What should be the next target to develop drugs for?
I am glad that you know these things, but cancer research has still failed society as a whole.
3 of my immediate family have had cancer, 2 took chemo and it ruined their lives (it caused weak bones, their spines to virtually dissolve, which led to surgeries to insert plates and things, which have failed multiple times, it has been a mess).
The third was not eligible for chemo because they were too sick and they had an existing case of lupus. So we started trying things -- probably 100 different things at first. What worked for them is taking Sanguinaria canadensis daily orally. It is now 15 years later and they still have cancer but are living a normal and healthy life.
You know, despite being the most effective treatment you could possibly hope for in this situation (besides an actual cure), there are only a few papers on Sanguinaria canadensis, and most research discredits it. Other friends of mine have tried chemo and died in a horrible way. Now you understand my criticism of cancer research. For all the money that has been spent, the most viable treatment available through a hospital is still a living nightmare.
That's cool. Where do you think that ___domain knowledge comes from? Did we just found it in a fortune cookie? Or does the cancer research conducted has something to do with that we have this knowledge?
> BCL6 is lymphoma.
That's not correct. BCL6 is a protein, or a gene which codes that protein. Mutations in BCL6 can lead to B cell lymphomas. BCL6 is not lymphoma.
> I am saying that it seems very straightforward as an approach to attempt to trigger a CDK cell death when BCL6 is present.
Excellent. Sounds like you are an oracle of oncological research roadmap. What should be the next target to develop drugs for?